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Voltage-gated sodium channels (VGSCs) are transmembrane proteins responsible for 
the initiation of action potentials in excitable tissues by selectively allowing sodium ions (Na+) to 
flow through the cell membrane. VGSC resurgent currents occur when an open channel blocker 
from the β4 subunit interacts with the α subunit, transiently blocking the movement of Na+ 
across the membrane. VGSC subtype Nav1.5 channels are expressed in cardiac tissue and 
irregularities in their activity can lead to pathophysiological conditions like arrhythmias that can 
lead to death. Pyrethroid insecticides have been used widely in agriculture, vector control and 
households around the world for decades and since this is the case, human exposure to these 
products has increased dramatically. It is important to understand the effects of these 
insecticides on humans, including how these insecticides affect the heart. This thesis highlights 
the effects of pyrethroids on β4 peptide mediated Nav1.5 VGSC resurgent currents. The aims of 
this thesis were to 1) determine Nav1.5 channel activity and if activity changes with exposure to 
the vehicle (DMSO) used to dilute pyrethroids; 2) investigate the β4 peptide’s effect on these 
Nav1.5 currents and if resurgent currents are produced; 3) investigate Nav1.5 channel activity 
when exposed to pyrethroids; and 4) investigate β4 peptide mediated VGSC resurgent current 
activity after exposure to pyrethroids. Standard whole-cell electrophysiology was used to 
determine electrophysiological and pharmacological properties of WT Nav1.5 currents. Results 
from these experiments showed that 1) Nav1.5  channel activity follows established 
understanding of VGSC: when depolarized a rapid and transient inward current is produced 
followed by a rapid inactivation;  2) DMSO did not affect activation and inactivation pattern; 3) 
the β4 peptide produced resurgent currents in Nav1.5; 4) pyrethroids alter electrophysiological 
viii 
properties of Nav1.5 by prolonging inactivation; and 5) β4 peptide mediated resurgent currents 
are larger after exposure to pyrethroids.  Overall, this thesis answers important questions 
regarding effects of pyrethroids on the cardiac VGSC and has implications for effects on health 
and highlights the necessity to be mindful of how pyrethroids are used in the future. 
 
Theodore R. Cummins, Ph. D., Chair 
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Chapter One: Introduction and Background 
Brief History of VGSC 
Alan Hodgkin and Andrew Huxley were physiologists that conducted a series of 
experiments on the squid giant axon and they discovered that the transmission of action 
potentials along the axon of the nerve was dependent on the changes in permeability of positive 
ions, sodium (Na) and potassium (K), across the plasma membrane (Hodgkin and Huxley, 1952a). 
They also found that the membrane potential of the squid giant axon was involved in regulating 
sodium conductance and the kinetics of sodium current and that this was all controlled by what 
is now called a voltage-gated mechanism (Hodgkin and Huxley, 1952b). Years later, a selective 
Na current blocker, tetrodotoxin (TTX), from the liver of a puffer fish, was discovered to block Na 
currents in lobster giant axons (Narahashi et al., 1964). Similar findings were discovered when 
saxitoxin (STX) was added to a frog vagus nerve prep. Like TTX, STX, also a Na current blocker, 
selectively interacted with receptors on the frog vagus nerve prep to eliminate Na current 
(Narahashi et al. 1967; Hille, 1968). From these studies it was determined that Na current was 
voltage-dependent and conducted through individual channels. Tools like patch-clamp recording 
was invented and implemented to examine Na currents in small isolated neurons (Hamill et al., 
1981; Sakmann et al., 1984) and has revolutionized the discovery and understanding of the 
different Na channel subtypes found in the human body. Although to date there are 9 sodium 
channel subtypes, this thesis will take a more in depth look at the Nav 1.5 isoform. But before 
we take a closer look at the Nav1.5, it is fitting to introduce the structure and function of the 
voltage-gated sodium channel in general.  
Structure and Function of VGSC 
Voltage-gated sodium channels are transmembrane proteins on many different types of 
tissues that participate in the influx of sodium ions and directly play a crucial role in propagating 
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action potentials in excitable tissues (Goldin, 2001). There are nine distinct alpha subunit genes 
that have been identified in mammals that encode VGSC isoforms (Nav.1.1 – Nav.1.9) which are 
found in different tissues (Goldin, 2002). For instance, Nav1.4 is largely expressed in skeletal 
muscle (Trimmer et al., 1989). Nav1.5 is mostly expressed in cardiac tissue (Rogart et al., 1989). 
Nav1.3, on the other hand, is predominantly expressed in immature neurons and 
downregulated in mature neurons (Beckh et al., 1989). Nav1.7, Nav1.8 and Nav1.9 are 
predominantly expressed in the peripheral nervous system (PNS). In contrast, in the mature 
central nervous system (CNS) neurons the predominant isoforms are Nav1.1, Nav1.2 and 
Nav1.6, however Nav1.1 and Nav1.6 are also expressed in the PNS (Trimmer et al., 2004). 
The alpha subunit is the primary functional unit of the VGSC and is a 220-260 kDa polypeptide 
that can associate with auxiliary proteins including the four β subunits (Navβ1 – Navβ4) which 
are 30-40 kDa polypeptides.  VGSC alpha subunit consists of four transmembrane domains (DI-
DIV) linked by intracellular loops wherein each domain consists of six transmembrane segments 
(S1 – S6; see Figure 1.) (Noda et al., 1984). Each of the S4 segments are made up of four to eight 
positively charged amino acids (arginine and lysine) that act as voltage sensors and these S4 
segments move within the membrane, in response to membrane voltage (or potential) changes, 
thus, creating various gating configurations that allows sodium ions to selectively flow inward 
through the channel (Noda et al., 1984; Catteral et al. 2000).  
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Figure 1. Linear schematic representation of the α subunit for the Nav1.5 voltage-gated 
sodium channel. The α subunit consists of four homologous transmembrane domains (DI—DIV). 
Each domain contains six transmembrane segments (S1—S6). S1-S4 serve as the voltage sensor 
of the channel and S5-S6 form the pore. This figure was adapted from Zifan Pei.  
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Simply put, VGSCs change between gating configurations that either allow sodium ions 
to flow through (open state) or do not allow sodium ions to flow through (inactive state and 
closed state) See figure 2. Closed refers to the configuration of the VGSCs at negative (or 
hyperpolarized) membrane potentials where the channel is available to open in the event the 
membrane changes to more positive (or depolarized) membrane potentials. In response to the 
depolarization of the membrane the VGSCs change to an open configuration and allow the 
selective inward movement of Na ions through the channel. Within roughly two milliseconds of 
opening the sodium currents are then terminated by channel inactivation.  The typical mode of 
inactivation is fast inactivation where the cytoplasmic linker between DIII-DIV (see Figure 1), 
which includes the IFM (Isoleucine-Phenylalanine-Methionine) particle, also known as the 
inactivation particle, binds and occludes the pore which stops the inward flow of sodium ions 
(West et al. 992; Moorman et al., 1990). In one experiment a triple mutation of IFM to QQQ 
(glutamine) in Nav1.2, a brain VGSC was shown to slow down inactivation (West et al., 1992). 
Along similar lines another experiment a single point mutation of F (phenylalanine) to Q in 
hNav1.5 also slowed down the rate of inactivation (Bennett et al., 1995). The findings of these 
two experiments support the hypothesis that cytoplasmic linker between DIII and DIV and the 
IFM particle play an integral role in the inactivation of VGSCs. 
However, fast inactivation is not the only type of inactivation. Studies show that there is 
also a slower component of inactivation, particularly in cardiac channels (Vilin et al., 1999). Slow 
inactivation happens when the membrane is depolarized for a long period of time and usually 
takes seconds to minutes for the channel to recover.  Typically, once the channel is inactivated, 
by either mechanism, it becomes refractory and it requires repolarization of the membrane to 
recover before they are available again (Armstrong et al., 1974).  
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Nav1.5 Sodium Channels 
The Nav1.5 VGSC is the predominant VGSC found in cardiac muscle (Rogart et al., 1989) 
and it plays a critical role in the initiation and propagation of action potentials throughout the 
heart. Similar to the other types of VGSCs, Nav1.5 undergoes conformational changes between 
ion-conducting (open) and non-conducting (inactive and closed) in response to change in 
membrane potential. 
Cardiotoxicity has been reported as a result of pyrethroid intoxication.  There is a 
specific cardiac sodium channel isoform (Nav 1.5) which has important clinical significance in 
that its mutation are implicated in malignant cardiac arrhythmias (Spencer et al., 2001).  We 
predict that resurgent currents caused by Cypermethrin and Permethrin intoxication also play a 
role in malignant cardiac arrhythmias that can lead to health complications or death. 
Resurgent Currents 
Resurgent sodium currents were first discovered in cerebellar Purkinje neurons (Raman, 
et.al., 1997). They are produced when the open-channel blocker unbinds the pore during 
intermediate repolarizing potentials following depolarization. After depolarizing potentials open 
sodium channels some fraction of the channels can go through a blocked state that is faster 
than and different from classic fast inactivation. As the channel repolarizes to more negative or 
intermediate potentials the blocker unbinds and allows the movement of sodium ions through 
the pore producing resurgent current, after which the channels inactivate or deactivate (Raman 
et al., 2001) (see Figure 2). Rapid firing is permitted here because resurgent currents allow 
channels to cycle between open, blocked and unblocked states which bypasses fast inactivation 
that is important for the refractory period following an action potential. The rate of fast 
inactivation is a significant determinant of resurgent sodium current generation because it is 
believed that the open-channel blocker competes with the intrinsic fast inactivation particle 
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when binding to the channel pore. Studies using toxins and disease mutations have 
demonstrated that slower rates of fast inactivation enhances resurgent current generation 
(Jarecki, et al., 2010). 
The first identified endogenous open channel blocker implicated in resurgent current 
generation is Navβ4. There are a few studies that demonstrate the significance of Navβ4 for the 
generation of resurgent cure. One study shows that Navβ4 – null mice do not have the ability to 
generate resurgent sodium current in medium spiny neurons of the striatum (Miyazaki, et al., 
2014). Another study showed that knockdown of Navβ4 in dorsal root ganglion (DRG) sensory 
neurons decreased resurgent sodium current but when Navβ4 is overexpressed resurgent 
currents are increased in the Nav1.6 isoform (Barbosa, et al., 2015).  Yet, another study showed 
that the knockdown of Navβ4 using small interfering RNA in cerebellar granule neurons 
completely wipes out resurgent sodium current, but interestingly, the resurgent current can be 
restored with the addition of a Navβ4 peptide (Bant, et al., 2010). However, co-expression of the 
VGSC alpha subunit and Navβ4 in HEK293 cells is not sufficient to produce resurgent sodium 
currents which suggests that other modulatory proteins and cellular background factors are 
critical.  Although this is the case, the Navβ4 peptide, made up of the membrane proximal C-
terminal portion of the Navβ4, Navβ4154-167 (KKLITFILKKTREK), acts as an open channel blocker 
and produces resurgent sodium current in HEK293 cells (Greico, et al., 2005).   
A depolarizing drive that approaches threshold for firing additional action potentials is 
caused by the momentary reopening of channels after the unbinding of the open-channel 
blocker. Studies show that channels that undergo open-channel block recover faster and are 
available sooner after an action potential spike decreasing the refractory period after an action 
potential (Theile, et al., 2011; Tan, et al., 2014). In fact, sodium currents have been shown to 
flow during the refractory period between action potentials and these currents are predicted to 
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enhance neuronal excitability (Raman, et al., 1999). Therefore, preventing resurgent current 
generation by knockdown of Navβ4 decreases spontaneous firing and repetitive firing with long 
depolarization stimuli (Barbosa, et al., 2015). These findings have also been demonstrated in 
modeling studies (Khaliq, et al., 2003).  
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Figure 2. Resurgent sodium current.  A, After a strong depolarization, sodium channels 
transition from the resting closed-state to open, allowing influx of sodium. Within milliseconds, 
the channel inactivates and remains inactivated until the membrane potential has been 
sufficiently hyperpolarized. This cycle of events underlies the action potential refractory period. 
B, Following a strong depolarization, a blocking particle (likely the C-terminal portion of the 
auxiliary Navβ4 subunit) can occlude the open-channel before the inactivation gate can bind, 
thus resulting in open-channel block. Following a hyperpolarization to an intermediate potential, 
the blocker is expelled resulting in an additional surge in sodium current. C, Representative 
resurgent sodium currents recorded from a large Nav1.8-null DRG neuron. The traces are 
magnified in the right panel to better see the resurgent currents. D, The voltage-dependence of 
the resurgent currents is shown by plotting the peak resurgent current amplitude against the 
repolarization pulse potential. Adapted from Theile and Cummins 2011). 
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Pyrethroid Insecticides 
Pyrethrum is a substance extracted from the flowers of Chrysanthemum cinerariaefolium 
and Chrysanthemum cineum and has been recognized for its insecticidal properties since the 
1800’s when they were used by Caucasian tribes and in Persia to control body lice (Casida 1980). 
The six active insecticidal compounds of pyrethrum are called pyrethrins and are named pyrethrin 
I, pyrethrin II, cinerin I, cinerin II, jasmolin I and jasmolin II. These pyrethrins are localized in the 
secretory ducts of the seed bearing fruit, where they are protected from photodecomposition and 
isolated so they are not toxic to insects that come into contact with pyrethrum flowers (Casida 
1980). The process to extract these pyrethins involves picking and drying the petals of the flowers 
and then grinding the petals into powder form and extracting the pyrethrins with hexane. After 
which, the hexane is evaporated and what is left is a dark substance containing 30% pyrethrins 
(Casida 1980). This substance can now be used as an insecticide with many different types of 
applications in different settings to knock down or control insect populations. 
One of the disadvantages of the naturally occurring pyrethrum as an insecticide is that it 
is not stable in light and air, which limit its insecticidal effectiveness in crop protection and other 
insect control contexts where residual activity is paramount. The development of synthetic 
pyrethroids is the result of efforts to modify the structure of the natural pyrethrins in order to 
increase photo stability while retaining the potent and rapid insecticidal activity and relatively low 
acute toxicity of pyrethrum. The past several decades of research and development by the 
agrochemical industry, academic research laboratories and by the government have resulted in 
1,000 different pyrethroid insecticides and a plethora of uses in agriculture, veterinary, medical 
and household pest control (Elliott 1989; Thatheyus et al. 2013). Synthetic pyrethroid 
development has involved structural modification and biological evaluation, so that the collection 
of present day commercial insecticides identified as pyrethroids are compounds that are several 
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steps removed from the pyrethrin structures. Most of these synthetic pyrethroids were 
discovered by sequentially replacing structural elements of the pyrethrins with novel structural 
moieties that were chosen to conserve the molecular shape and physical properties of the 
structure used as the template. Later, instead of using the pyrethrins as templates, subsequent 
stages used to develop new pyrethroids made use of the newly discovered synthetic pyrethroids 
with desirable insecticidal activity, stability and other properties as templates for the further 
design of new synthetic pyrethroids. For example the first wave of synthetic pyrethroids made 
use of pyrethrins as templates and one of the synthetic insecticides developed was permethrin, a 
Type I pyrethroid, after which, permethrin was used as a template to develop cypermethrin, a 
Type II pyrethroid. 
Mode of Action of Pyrethroid Insecticides 
The primary mode of action of pyrethroid in both insects and mammals is disruption of 
the VGSC function. Evidence points to the fact that pyrethroids bind to the α subunit of the 
VGSC. In a study that expressed Nav 1.2 α subunit in Chinese Hamster ovary cells (CHO cells) 
found that the presence of the α subunit was sufficient for pyrethroids to produce their 
characteristic effects on sodium channel function (Trainer et al., 1997). This conclusion is 
supported by another study that showed that pyrethroids altered the current produced by Nav 
1.2 and Nav 1.8 α subunit expressed in oocytes in the absence of coexpression with β subunits 
(Smith et. al., 1998; Smith et. al., 2001). Interestingly, coexpression of the β1 subunit with Nav 
1.2 increased the sensitivity of this channel compared with expression of Nav 1.2 alone 
indicating that the β subunit modulates the affinity of pyrethroid interaction with the channel 
(Smith et.al, 2001). Lastly, studies show that mutations in the VGSC α subunit of insects and 
mammals alters the sensitivity of VGSCs to effects of pyrethroids supporting the claim that 
pyrethroids interact with the α subunit (Lee et. al., 2001; Wang et. al., 2001).  
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Pyrethroids are known to alter the normal functioning of insect VGSC which are integral 
in mediating the transient increase in the sodium permeability of the nerve membrane that 
underlies the nerve action potential (Soderlund et. al., 1989). Pyrethroids slow the activation (or 
opening) of VGSCs and slow the rate of inactivation (or closing) of VGSCs. In addition they shift 
to more hyperpolarized potentials the membrane potential at which VGSCs initially activate (or 
open). The result is that the sodium channels open at more hyperpolarized potentials (i.e., after 
smaller depolarizing changes in membrane potentials) and remain open longer, allowing more 
sodium ions to cross and further depolarize the membrane. Studies show that in general, type II 
pyrethroids delay the inactivation of VGSCs significantly longer than the type I pyrethroids 
(Narahashi 1996). Type I pyrethroids keep channels open long enough to cause repetitive firing 
of action potentials while Type II pyrethroids keep channels open for so long  that the 
membrane potential ultimately becomes depolarized so much that it can no longer generate 
action potentials, which is called depolarization dependent block (Soderlund et al, 2002).  It is 
believed that these differences in prolongation of channel openings contribute to the 
differences between two distinct syndromes (see below) after exposure to Type I and Type II 
pyrethroids respectively (Ray 2001).  
Pyrethroids act as contact poisons affecting the insect’s nervous system by causing 
multiple action potentials in the nerve cells, primarily by delaying the closing of the VGSCs 
(Costa, 1997). Most insecticide products containing pyrethroids usually contain a synergist, such 
as piperonyl butoxide, which restricts an enzyme that insects use to detoxify the pyrethroid 
thereby making the insecticide more effective (Tomlin, 1994). Perturbation of sodium channel 
function by pyrethroids is stereospecific (Lund et. al., 1982). The sterioisomers that disrupt the 
VGSCs the most also have the most insecticidal activity (Ray, 2001). Pyrethroid exposure in 
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insects is predominately through the insect cuticle. Rapid absorption into the insect causes a 
disruption of neurotransmission causing paralysis and possibly death within seconds to minutes.  
Pyrethroid insecticides were introduced into common use for the control of insect pests in 
agricultural settings and in disease vectors over three decades ago. Their use had grown to 
represent 18% of the dollar value of the world insecticide market by 2002 (Pickett 2004). These 
Pyrethroid insecticides are not only effective in controlling agricultural pests, they are also used 
as a front line solution in efforts to combat malaria and other mosquito-borne diseases even 
with threats that there is already resistance forming in vector populations (Ranson et al. 2011). 
Pyrethroids are also used widely as ingredients in household insecticides and ectoparasite 
control products for domesticated pets. Pyrethroid use in agriculture and vector control has 
increased tremendously in recent years due to the reduced use of chlorinated, carbamate, and 
organophosphate pesticides causing an increased in human exposure to pyrethroids (Power et 
al., 2007). The unregulated use of these pesticides in the home environment increases the risk 
of exposure and potential adverse effects in the general population (Naeher et al. 2010).  
Pyrethroid Intoxication in Mammals 
Humans and other mammals quickly metabolize pyrethroid compounds to non-toxic 
substances so exposure to these compounds is usually unthreatening. However, reports of 
accidental exposure (occupational) and intentional poisoning (suicide attempts) due to 
pyrethroid insecticides are common (Chen et al., 1991). 
Categorizing pyrethroid insecticides is complicated due to the existence of two distinct 
intoxication syndromes in mammals that are determined by different structural subgroups of 
the insecticide class. The first systematic description of the signs of pyrethroid intoxication in 
rats following either oral or intravenous dosing manifested the same syndrome which included 
hypersensitivity and aggression followed by tremors and convulsive twitching, coma and death 
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(Verchoyle et al. 1972). The observed difference between oral and intravenous dosing was the 
speed at which the symptoms of intoxication manifested. When the α-cyano-3-phenoxybenzyl 
moiety (α-cyano moiety) was added to the pyrethroid insecticide a different intoxication 
syndrome was identified. A landmark study reported salivation without lacrimation followed by 
jerking leg movements and progressive writhing convulsions, called choreoathetosis (Barnes et 
al. 1974).  
A subsequent study described both intoxication syndromes following intravenous 
administration, thus establishing a taxonomy of pyrethroid intoxication in mammals that is still 
useful to the present (Verschoyle et al. 1980). The signs of intoxication first described for 
pyrethroids, hypersensitivity and aggression followed by tremors and convulsive twitching, 
coma and death (Verchoyle et al. 1972) was designated the T (tremor) syndrome. By contrast, 
the signs of intoxication produced by the pyrethroids with the α-cyano moiety, salivation 
without lacrimation followed by jerking leg movements and progressive writhing convulsions, 
called choreoathetosis (Barnes et al. 1974), was designated the CS (choreoathetosis with 
salivation) syndrome.  
An alternative nomenclature (Type I and Type II) was proposed for groups of pyrethroids 
based on both their syndromes of intoxication, chemical structures, signs of poisoning in insects, 
and action on insect nerve preparations (Lawrence et al. 1982) (Gammon et al. 1981). Type II 
pyrethroid insecticides contain the α-cyano moiety (e.g. cypermethrin) whereas Type I 
pyrethroid insecticides are made up of compounds that are lacking the α-cyano moiety (e.g. 
permethrin) see figure 3. The Type I and Type II nomenclature is often used in a manner akin to 
the T and CS nomenclature, such that the Type I pyrethroids are generally considered to 
produce the T intoxication syndrome and the Type II pyrethroids are considered to produce the 
CS intoxication syndrome (Lawrence et al. 1982). The interchangeability between the Type I/II 
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nomenclature and T/CS nomenclature are useful as a general classification scheme and are 
generally used in the published literature. However, there are a number of pyrethroids that do 
not fit neatly into these schemes because there are Type I/II pyrethroids that can produce 
overlapping syndrome (T/CS) of intoxication. (Soderlund et al. 2002). Nonetheless, for the 
purposes of this thesis the reference to Type I and Type II pyrethroids represents the structural 
class and the pattern of intoxication syndrome of pyrethroids.  
Hypothesis and Specific Aims 
As a result of the evidence in literature (see above) showing that Type I and Type II 
pyrethroid insecticides target the VGSC and slows steady-state inactivation and that the 
literature showing (see above) that the β4 peptide mimics the open channel blocker that 
occludes the pore and leads to resurgent currents we formed a hypothesis that β4 mediated 
resurgent currents in Nav1.5 VGSCs increase after exposure to Type I and Type II pyrethroid 
insecticides. 
This thesis highlights the effects of Type I and Type II pyrethroid insecticides on β4 
peptide mediated Nav1.5 VGSC resurgent currents. The aims of this thesis were to first 
determine wild-type Nav1.5 channel activity and whether channel activity changes with 
exposure to the vehicle (DMSO) used to dilute insecticides. Results from the first aim, although 
not recorded in this thesis, demonstrated that DMSO at 0.1% has no significant effect on the 
wild-type Nav1.5 channel activity.  Since this was the case, we moved forward with 
electrophysiological experiments using 0.1% DMSO as a vehicle in which we diluted 2µM and 
10µM pyrethroid insecticides before exposing cells. The second aim investigated the β4 
peptide’s effect on these Nav1.5 VGSC currents and whether or not resurgent currents were 
produced. The results from the second aim demonstrated that in the presence of β4 peptide the 
Nav1.5 VGSC produces noticeable resurgent currents. The third aim investigated Nav1.5 channel 
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activity when exposed to Type I and II pyrethroid insecticides (Permethrin and Cypermethrin 
respectively). The results from the third aim demonstrated that exposure to the insecticides 
effects the rate of steady-state inactivation in Nav1.5 VGSCs as it produced significant tail and 
persistent currents.  Finally, the fourth aim investigated β4 peptide mediated VGSC resurgent 
current activity after exposure to Type I and II pyrethroid insecticides. The results from the 
fourth aim demonstrated that β4 mediated resurgent currents increase after exposure to the 
pyrethroid insecticides.  
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Figure 3. Chemical structure of Type I and Type II Pyrethroid Insecticides, Permethrin and 
Cypermethrin respectively. The two most commonly used pyrethroids in agriculture are 
Cypermethrin and Permethrin (Atchison et al., 2012).   
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Chapter Two: Materials and Methods 
Preparation of Stably Transfected Cell Lines 
Experiments investigating the effects of pyrethroid pesticides on β4 mediated resurgent 
currents in Nav1.5 channels were done using stably transfected cell lines. To make the stable 
cell line, Human embryonic kidney cells (HEK293 cells; American Type Culture Collection; 
Manassas, VA, U.S.A.) were used. They were incubated under typical tissue culture conditions 
(5% CO2; 37 oC) in complete Dulbecco’s Modified Eagle Medium (DMEM; Invitrogen, Grand 
Island, NY, U.S.A.) supplemented with 10% fetal bovine serum (FBS; Cellgro, Herndon, VA, U.S.A) 
and 1% penicillin/streptomycin (Invitrogen Grand Island, NY, U.S.A.). The calcium phosphate 
precipitation method was used to perform transfections of Nav1.5 cDNA. The calcium 
phosphate precipitation method is as follows: solution 1 (40 µl 2X HEPES buffer) was added 
dropwise to solution 2 (4 µg of channel cDNA at 1µg/µl concentration and 5µl of 2M CaCl2; use 
sterile water to bring volume to 40µl) and was gently mixed using a pipette. The calcium 
phosphate-DNA mixture was incubated at room temperature for 30 minutes after which, it was 
added to HEK293 cells incubated in serum-free DMEM for one hour on a 100x20 mm culture 
petri dish. Following incubation for 12-24 hours at 37 oC, the cells were washed with fresh 
complete DMEM medium. The Nav1.5 cDNA was subcloned into the pcDNA 3.1 (+) vector using 
the HindIII Xbal restriction enzymes. This vector contains the neomycin (G418) resistant gene for 
the purpose of using G418 treatment to select for HEK cells stably expressing Nav1.5. After 48 
hours of incubation in complete DMEM medium (10% FBS, 1% pen/strep) the antibiotic (G418, 
Geneticin; Cellgro, Herndon, VA) was added to the media to select for neomycin-resistant 
HEK293 cells. After 2-4 weeks in G418, HEK293 cell colonies resistant to G418 were isolated and 
allowed to grow on 12 mm glass coverslips (Microscope Cover Glass; Fisherbrand, Pittsburg, PA, 
U.S.A) coated in Laminin. Isolated cells from these colonies were tested for Nav1.5 channel 
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expression using whole-cell patch-clamp recording techniques. Colonies containing cells 
producing more than 1 nA of Nav1.5 current were used for subsequent experiments 
Chemicals 
Stock solutions of Permethrin (Sigma-Aldrich International, St. Louis, MO, U.S.A.) and 
Cypermethrin (Sigma-Aldrich International, St. Louis, Mo, U.S.A.) prepared in 0.1% 
Dimethylsulfoxide (DMSO, Sigma Aldrich International, St. Louis, Mo., U.S.A.) were aliquoted 
and stored at room temperature. For experiments, the insecticides were diluted in extracellular 
bathing solution to achieve a final concentration of 0.02 – 10µM in a final volume of 400µl in a 
micro centrifuge tube which was transferred, all 400µl by pipette, to the reservoir containing 
the cover slip with the stably transfected Nav1.5 HEK293 cells. After 10 minutes whole cell 
patch-clamp experiments were conducted.  
The β4 peptide consisting of part of the C-terminal tail (KKLITFILKKTREK-OH) of the full-
length β4 subunit was added to the intracellular pipette solution to induce Nav1.5 resurgent 
currents in stably transfected HEK293 cells. For this, stock solution of β4 peptide (Biopeptide 
Co., San Diego, CA) in water, (stored in -20oC) was diluted in the intracellular pipette solution to 
achieve a final concentration of 200µM in a final volume of 500µl. This β4 peptide solution was 
used to back fill the recording pipette.  
Solutions 
1. Extracellular Bathing Solution 
The standard extracellular bathing solution was used during all voltage clamp whole-cell 
electrophysiology experiments. The extracellular bathing solution containing (in mM): 140 NaCl, 
1 MgCl2, 3 KCl, 1 CaCl2 and 10 HEPES, pH 7.3 (adjusted with NaOH), Osmolarity (280-300 mOsm, 
adjusted with NaCl) was measured using a Wescor VAPRO Vapor Pressure Osmometer 5520 
(Logan, Ut, U.S.A). In experiments involving the pyrethroid pesticides effects on Nav1.5 kinetics 
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and β4 mediated resurgent currents, the pesticides were diluted to a final concentration of 0.02 
– 10µM in extracellular bathing solution in a micro centrifuge tube, final volume of 400µl before 
being transferred by pipette to the reservoir containing the cover slip with the stably 
transfected Nav1.5 HEK 293 cells. 
2. Intracellular Pipette Solution 
The Intracellular pipette solution was used in all voltage clamp whole-cell 
electrophysiology experiments. The intracellular pipette solution containing (in mM): 140 CsF, 
10NaCl, 1.1 EGTA and 10 HEPES, pH 7.3 (adjusted with CsOH), osmolarity 280-300 (adjusted with 
CsCl) was measured using a Wescor VAPRO Vapor Pressure Osmometer 5520 (Logan, Ut, U.S.A). 
The β4 peptide was diluted in pipette solution before being back-filled into the pipette. 
Whole Cell Patch-Clamp Recordings 
Whole cell patch-clamp recordings were conducted at room temperature (~ 21 degrees 
Celsius) using a HEKA patch clamp EPC 10 amplifier. A Windows-based Pentium IV computer 
using the Pulse program (v 8.78, HEKA Elektronik, Lambrecht/Pfalz, Germany) was used to 
acquire data. Fire-polished glass pipettes (measured at ~ 1 micron) were fashioned from 100ul 
Calibrated Pipets (Drummond Scientific Company, Broomall, PA, U.S.A) using a Sutter P-1000 
Flaming/Brown Micropipette Puller (Novato, CA, U.S.A) and fire-polished using a Micro Forge 
MF-830 (Narishige, Japan). To hold coverslips containing stably transfected HEK293 cells during 
whole cell patch-clamp recordings, lids from 35 mm cell culture petri dishes (Corning Inc., 
Corning, NY, U.S.A) were filled with elastomer from 184 Silicone Elastomer Kit (Sylgard®, World 
precision Instruments Inc., Sarasota, FL, U.S.A.), mixed with a curing agent (included in kit), and 
allowed to solidify. Once solidified, a scalpel was used to cut around a single 12mm coverslip 
into the silicone to create a reservoir that could hold a coverslip and 400µl of extracellular 
solution. 
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The recording dish containing stably transfected HEK293 cells was mounted on an 
inverted Nikon microscope. The microscope was placed on a TMC vibration isolation table (63-
500 Series, Technical Manufacturing Company, Peabody, MA, U.S.A.) to reduce all negative 
effects of vibration on the experiments. All whole cell patch-clamp electrophysiological 
experiments were conducted without the use of a Faraday cage. Instead, multiple wires were 
used to ground every metal surface that had the potential to serve as an antenna for unwanted 
electrical noise. These wires converged and connect at a single point on the isolation table; and  
from that point a single wire was connected to the ground input of the HEKA EPC 10 amplifier. 
Isolated, single cells on the cover slip were selected for whole cell patch-clamp 
electrophysiology. Each whole cell patch-clamp electrophysiological recording was collected 
using a new fire-polished pipette, back-filled with appropriate intracellular pipette solution. 
Once filled with the appropriate intracellular pipette solution, and once the pipette was 
submerged in the extracellular bathing solution in the dish, the recording electrode had an 
approximate resistance of 1.0 - 1.5 MΩ. The offset potential of the EPC 10 amplifier was zeroed 
with the electrode almost touching the cell of interest. A silver chloride coated silver wire served 
as a reference electrode with one end connected to the ground input of the amplifier head 
stage and the silver chloride coated end placed into the reservoir containing the coverslip with 
the stably transfected HEK 293 cells and extracellular bathing solution. The liquid junction 
potential for all solutions was not corrected for during these experiments and data analysis.  
Once a cell membrane-glass pipette interaction was formed, creating over 1GΩ resistance, 
suction was applied to establish the whole-cell recording configuration. All voltage protocols 
were started five minutes after entering the whole cell configuration, which allowed time for 
diffusion of the β4 peptide when experiments called for it. Series resistance errors were 
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compensated to be under 5mV using resistance compensation and passive leak currents were 
cancelled by P/-5 subtraction. 
For all experiments, recordings were made in the presence of extracellular solution 
containing drug or vehicle control. Vehicle control was 0.1% DMSO final concentration in 
extracellular solution without the pyrethroid pesticice. Each coverslip was recorded from for up 
to one and half hours before discarding. 
Data Analysis 
All voltage-clamp electrophysiological recording experimental data were analyzed using 
the Pulsefit (v 8.65, HEKA Electronic, Germany), Prizm Graph-pad (7.03) and Microsoft Excel 
software programs. Normalized conductance – voltage relationships (G-V) were derived using 
the function: GNa=IMax/(Vm-ENa).  GNa is conductance of sodium channel, IMax is the peak current 
density in response to the test pulse, Vm stands for the test pulse potential, and ENa is the 
measured sodium channel reversal potential. Slope factors of activation and steady-state 
inactivation curves were calculated using the general Boltzman function: I/Imax = (1/1+e (V –V0.5)/k 
where I is measured current, Imax is maximum current, V is command voltage, V0.5 is voltage at 
which the normalized current value is 0.5, and k is slope factor describing the steepness of the 
relationship. Goodness of fit was set at R2 > 0.90 for all fits. Results are presented as mean + 
S.E.M., and error bars in the figures represent SEs. Statistical significance was set at p < 0.05 for 
all experiments. 
Resurgent Current Analysis 
 Cells were assayed with a step protocol that initially depolarized the membrane to 
+30mV for 20ms from the holding potential, followed by repolarizing voltage steps from +15mV 
to -85 for 100ms in -5mV increments to test for resurgent currents; cells were then returned to 
their holding potential. Resurgent current amplitudes were measured from the leak-subtracted 
22 
baseline to the peak after 3.0ms into the repolarizing pulse to avoid contamination from tail 
currents. Relative resurgent currents were calculated by dividing peak resurgent current by the 
peak transient current and expressed as a percentage of the peak transient current. The peak 
transient current was determined as the peak from the h∞ protocol. Student’s t test was used to 
examine the statistical significance of relative resurgent current amplitude between groups.  
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Chapter Three:  Results 
Whole-cell voltage-clamp recordings were obtained from HEK293 cells stably expressing 
hNav1.5 channels (Nav1.5 cells). There was no observed significant change in the voltage-
dependence of activation when Nav1.5 cells were exposed to Type I and Type II pyrethroid 
insecticides compared to control (see Figure 4).  However, Type I and Type II pyrethroid 
insecticides did shift steady-state inactivation of Nav1.5 cells (see Figure 5).  Cypermethrin 
shifted inactivation by ~5mV in the negative direction and Permethrin shifted Nav1.5 
inactivation by ~5mV in the positive direction. However both insecticides resulted in incomplete 
inactivation as evidenced by the increased fraction available at voltages between -50mV and       
-10mV. 
We also examined the rate of inactivation during depolarizations to 0 mV. In Nav1.5 
cells we observed two components for the time course of fast-inactivation; a fast component 
and a slow component. Measuring the Tau time constants we found that Permethrin and 
Cypermethrin significantly increased the Tau for the slow inactivation component (see Figure 6). 
Cypermethrin had a much greater effect on the slow time constant but Permethrin also 
significantly slowed the fast time constant compared to control cells. 
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Figure 4. Effects of Permethrin and Cypermethrin on activation of sodium channel Nav 1.5. 
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Figure 5. Effects of Permethrin and Cypermethrin on steady-state inactivation of sodium 
channel Nav1.5. 
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Figure 6. Effect of Permethrin and Cypermethrin on time constants of Nav1.5 inactivation. 
Time constants were obtained by fitting double exponential functions. Student t-test was used 
to determine significance. NS, not significant; *, p-value < 0.05; **, p-value < 0.01. 
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We next examined sodium currents during repolarizing steps following a strong 
depolarization.  A strong depolarization (20 ms at +30 mV) from the holding potential is followed 
by repolarizing voltage steps ranging from +15 mV to -85 mV for 100 ms in -5 mV increments. 
This protocol can be used to examine resurgent sodium currents in the presence of the β4 
peptide. In the absence of the β4 peptide the control panel shows a complete inactivation with 
no evidence of tail currents or persistent currents during the repolarizing voltage potentials (see 
Figure 7). However, after exposure to Permethrin and Cypermethrin we see significant 
production of tail currents and persistent current during the repolarizing voltage potentials.  
In the presence of the β4 peptide the control panel shows β4 mediated resurgent current during 
the repolarizing potentials. After exposure to Permethrin and Cypermethrin we see larger 
resurgent currents during the repolarizing potentials compared to control. We also see that 
Cypermethrin produces larger and slower resurgent current compared to the resurgent current 
that Permethrin produces. It appears that Permethrin and Cypermethrin have a synergistic 
effect and combined with the β4 peptide they increase the size of the resurgent currents.  
It is important to note the repolarization induced currents differ in the absence and presence of 
the β4 peptide. In the absence of the β4 peptide, the insecticides increase persistent currents 
during the depolarization which leads to instantaneous classic “tail currents” during the 
repolarizing pulses. Because inactivation is virtually complete under control conditions, no tail 
currents are observed in the absence of insecticides (see Figure 7 control). By contrast in the 
presence of the β4 peptide resurgent currents with a delayed onset compared to tail currents 
are observed (see Figure 8). The resurgent currents are significantly larger than the tail currents 
(note the different scales in Figure 9). Cypermethrin induced resurgent currents are both larger 
and slower than control and Permethrin induced tail currents. 
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Figure 7. Representative trace of effects of Permethrin and Cypermethrin on Nav1.5 currents 
elicited by repolarizations. Both Permethrin and Cypermethrin increase, what appears to be 
persistent and tail current in Nav1.5 VGSCs. 
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Figure 8. Representative traces illustrating the effects of Permethrin and Cypermethrin on β4 
mediated resurgent currents. These traces show that the Type I and Type II pyrethroid 
insecticides act synergistically with the β4 peptide to increase resurgent currents in Nav1.5 after 
exposure of cells to Permethrin and Cypermethrin.  
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Figure 9. Repolarization induced current measurement in Nav1.5 cells before and after 
exposure to Permethrin and Cypermethrin. Permethrin and Cypermethrin produce significant 
repolarization-induced currents in Nav1.5 without β4 compared to the control. After Nav1.5 
cells are exposed to Permethrin and Cypermethrin β4 mediated resurgent increase.  
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Chapter Four: Discussion 
Results for this thesis demonstrate that 1) Nav1.5 channel activity does not change with 
exposure to the vehicle (DMSO) used to dilute Type I and Type II pyrethroids, data is not shown 
in the thesis; 2) the β4 peptide induces resurgent currents in Nav1.5; 3) Type I and Type II 
pyrethroids alters electrophysiological properties of Nav1.5 channel activity by slowing down 
steady-state inactivation; and 4) β4 peptide mediated VGSC resurgent current activity increases 
after exposure to Type I and II pyrethroid insecticides.   
As mentioned above Permethrin is a Type I pyrethroid insecticide and Cypermethrin is a 
Type II pyrethroid insecticide. The major difference between Type I and Type II pyrethroids is 
that the Type II insecticide has an added α cyano moiety (see Figure 3).  This added α cyano 
moiety changes Intoxication syndromes.  Intoxication syndromes are different because the Type 
I and Type II pyrethroids keep channels open and keep them from inactivating but studies show 
that Type II pyrethroids keep sodium channels open longer than Type I pyrethroids (see above).  
We see this demonstrated in how much the B4 peptide mediated resurgent current exposed to 
the Cypermethrin is slowed down compared to control and the Permethrin panel (see Figure 8). 
Since this is the case, Cypermethrin would lead to more pronounced cardiac toxicity because the 
longer amount of time it keeps the channel open which will cause increased arrhythmias which 
can lead to death. As a result of these difference in the Type I and Type II pyrethroid insecticides 
and the different intoxication symptoms that are exhibited in mammals we could predict that 
these two pyrethroid insecticides would produce differences in cardiac toxicity. 
Future direction for this project should include increasing the sample size of all of the 
conditions (i.e. control, Permethrin with or without β4, and Cypermethrin with or without β4) so 
that statistical significance can be determined more convincingly. Also, since it appears that 
there is a synergistic relationship between the pesticides and the β4 peptide in the production 
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of resurgent current it would be interesting to see the effects of both Permethrin and 
Cypermethrin with or without β4 protein on myocyte sodium channel activity. This will help 
determine the relationship, whether additive, synergistic or antagonistic, between the Type I 
and Type II pesticides and how the two of these affect the β4 peptide mediated resurgent 
current in native myocytes. 
Testing the Type I and Type II pesticides with or without β4 peptide in myocytes from β4 
peptide knockout mice would be an informative step forward. All experiments in this thesis 
were conducted in Nav1.5 stably transfected HEK293 cells. One of the main limitations in using 
heterologous expression systems is that they are an artificial system and since this is the case 
any physiological significance would have to be extrapolated from the data. It is more suitable to 
determine physiological significance in the primary tissues where Nav1.5 channels are localized, 
such as the myocytes. In myocytes we can first test to see if there are any endogenous β4 
subunits using immunohistochemistry techniques. If β4 subunit is present we can test if it 
produces resurgent current using the resurgent current protocol. If it does produce resurgent 
currents we can see if the size of the resurgent currents are influenced by pesticide exposure. 
We can use selective knock-out β4 in myocytes and examine if toxicity of pyrethroid insecticides 
is reduced. 
Literature shows that these pesticides function by slowing down the inactivation of 
sodium channels. It would be fitting to see how these pesticides combined with the effects of 
the endogenous β4 or β4 peptide affect neuronal resurgent currents. Due to the pyrethroid 
insecticide intoxication symptoms it would be important to determine if the effects of pesticides 
and β4 peptide on neuronal channels are similar to those observed with Nav1.5. Resurgent 
currents in neurons could lead to altered excitability including potentially to ataxia and seizures. 
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In conclusion, this thesis addressed key questions about how Type I and Type II 
pesticides affect β4 mediated resurgent currents in Nav1.5 cells. The results of this thesis have 
provided important insights into how the Type I and Type II pesticides modulate the Nav1.5 
channel kinetics and how resurgent currents are modulated after exposure to the pesticides.  
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